Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Open-Label Study For the Development of a Method To Detect Dendritic Cell Recruitment in Alzheimer's Disease (DC RAD)

NCT05482867 is registered in ClinicalTrials.gov with MindImmune Therapeutics, Inc. as lead sponsor.

NCT NCT05482867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05482867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Open-Label Study For the Development of a Method To Detect Dendritic Cell Recruitment in Alzheimer's Disease (DC RAD)
Lead sponsor
MindImmune Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
November 28, 2022
Completion date
September 17, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

probable alzheimer's disease